GlassScriptPhysician profile
Cole Wootton
NPI 1881828556
$9,513.55
in general payments reported to CMS, 2019-2025
47 companies · $1,544 in 2025
The $1,544 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $991 · 2020: $875 · 2021: $1,482 · 2022: $1,393 · 2023: $1,589 · 2024: $1,639 · 2025: $1,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,736 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,736.10 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,127.53 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $1,079.35 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Abbvie INC. | $910.01 | 2020-2025 | Lupron Depot, Botox |
| Boston Scientific Corporation | $886.22 | 2019-2025 | Axonics, Rezum Generator, Ams 700 Cxr Rte Kit |
| Pfizer INC. | $637.66 | 2021-2025 | |
| Neotract INC. | $626.79 | 2019 | |
| Janssen Biotech, INC. | $536.97 | 2019-2025 | Erleada, Akeega |
| Medtronic USA, INC. | $398.02 | 2019-2020 | |
| Axonics, INC. | $393.62 | 2020-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $355.79 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $299.44 | 2020-2024 | Prolaris |
| Healthtronics Stone Solutions, LLC | $205.00 | 2021 | |
| Profound Medical Corp. | $201.49 | 2022-2023 | Tulsa-Pro |
| Teleflex LLC | $197.35 | 2021-2025 | Barrigel |
| Urogen Pharma, INC. | $116.26 | 2022-2025 | Jelmyto |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Wootton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.